MarioCastroMDMPH

Pulmonology • Kansas City, KS

Asthma & COPD, Critical Care Medicine, Interventional Pulmonology, Pleural Disease

Professor, Chief, Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine

Join to view full profile

Dr. Castro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Castro's full profile

Already have an account?

Office
4000 Cambridge St
MSN 3007
Kansas City, KS 66160
Phone+1 913-588-7529

Fax+1 913-535-2200

Summary

Dr. Mario Castro is a pulmonologist in Kansas City, KS and is affiliated with The University of Kansas Health System. He received his medical degree from University of Missouri - Kansas City School of Medicine and has been in practice 29 years. He specializes in asthma & copd, critical care medicine, interventional pulmonology, and pleural disease and is experienced in asthma, chronic obstructive pulmonary disease, lymphangioleiomyomatosis, sarcoidosis, and airway remodeling.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
University of Missouri Kansas City School of MedicineClass of 1988

Certifications & Licensure

KS State Medical License 2019 - 2025
MO State Medical License 1994 - 2025
FL State Medical License 1990 - 1994
IA State Medical License 1991 - 1994
MN State Medical License 1989 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Start of enrollment: 2004 Dec 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) Start of enrollment: 2008 May 01
Completed
Phase 3
Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
Completed
Phase 3
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
Completed
Phase 2
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study) Start of enrollment: 2010 Aug 01
Completed
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Start of enrollment: 2011 Apr 01
Completed
Phase 3
Long-acting Beta Agonist Step Down Study Start of enrollment: 2012 Mar 01
Completed
Phase 4
Severe Asthma Research Program Start of enrollment: 2012 Oct 01
Active, not recruiting
Washington University Severe Asthma Research Program III Start of enrollment: 2012 Oct 01
Active, not recruiting
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
Unknown status
Phase 2
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction Start of enrollment: 2014 Mar 01
Completed
Phase 2
Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

39 citations
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Matthew W McCarthy, Susanna Naggie, David R Boulware, Christopher J Lindsell, Thomas G Stewart
JAMA. 2023-01-24
291 citations
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations
Loren C. Denlinger, Brenda R. Phillips, Sima K. Ramratnam, Kristie R. Ross, Nirav R. Bhakta
American Journal of Respiratory and Critical Care Medicine. 2016-08-24
2484 citations
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung, Sally E. Wenzel, Jan Brozek, Andrew Bush, Mario Castro
The European Respiratory Journal. 2014-02-01

Press Mentions

Ivermectin Shown Ineffective in Treating COVID-19, According to Multi-Site Study Including KU Medical CenterDecember 1st, 2022
American College of Chest Physicians, Oct. 16-19October 31st, 2022
Biologic Dupilumab Shows Sustained Benefit in Asthma PatientsOctober 19th, 2022
Join now to see all